TLIS - Talis Biomedical's (TLIS) CEO Brian Coe on Q2 2021 Results - Earnings Call Transcript

Talis Biomedical Corporation (TLIS) Q2 2021 Earnings Conference Call August 10, 2021 4:30 PM ET Company Participants Emily Faucette – Senior Vice President-Corporate Communications and Investor Relations Brian Coe – Chief Executive Officer Doug Liu – Chief Operating Officer Roger Moody – Chief Financial Officer Conference Call Participants Derik De Bruin – Bank of America Mark Massaro – BTIG Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the Talis Second Quarter 2021 Earnings Call. [Operator Instructions] I would now like to turn the conference over to Ms. Emily Faucette, SVP, Corporate Communications and Investor Relations. Ma’am, please go ahead. Emily Faucette Good afternoon, and thank you for participating in today’s conference call. Joining me, we have Brian Coe, our Chief Executive Officer; Roger Moody, our Chief Financial Officer; and Doug Liu, our Chief Operating Officer. Earlier today, Talis released financial results and business progress for the quarter ended

For further details see:

Talis Biomedical's (TLIS) CEO Brian Coe on Q2 2021 Results - Earnings Call Transcript